News Archive
22 Dec 2015
eFFECTOR Therapeutics Raises $40 Million - Series B Financing
21 Dec 2015
Bayer and CRISPR Therapeutics AG join Forces to Discover, Develop and Commercialize Potential Cures for Serious Genetic Diseases
11 Dec 2015
CRISPR Therapeutics Appoints Tony Coles to its Board of Directors
11 Dec 2015
Senseonics Holdings, Inc. and ASN Technologies, Inc. Announce Closing of Merger
3 Dec 2015
Cytos Biotechnology and Kuros Biosurgery to combine to create Kuros Biosciences
2 Dec 2015
Kesios Therapeutics Raises £19 Million In Series A Financing
17 Nov 2015
Gynesonics Completes $46 million Equity Financing
12 Nov 2015
Sientra Appoints Jeffrey Nugent Chairman and Chief Executive Officer
26 Oct 2015
Vertex and CRISPR Therapeutics Establish Collaboration to Use CRISPR-Cas9 Gene Editing Technology to Discover and Develop New Treatments for Genetic Diseases
20 Oct 2015
Wilson Therapeutics Appoints Andrew Kay as Chairman
19 Oct 2015
Abingworth appoints Dr Shelley Chu
9 Oct 2015
Sientra Sends Letter to Plastic Surgeons Regarding Silimed-Manufactured Products
5 Oct 2015
Sientra Issues Statement Regarding Recent ANVISA Announcement
24 Sep 2015
Dear Doctor Letter
18 Sep 2015
Sientra® Prices Follow-On Public Offering of Common Stock
23 Jul 2015
GenSight Biologics Closes $36 Million Series B Preferred Stock Financing
23 Jul 2015
SutroVax raises $22 million in Series A
22 Jul 2015
Gynesonics Raises $43 million in Equity Financing
7 Jul 2015
Abingworth appoints Tim Haines and Kurt von Emster as joint Managing Partners
3 Jul 2015
MEDIAN Technologies announces a private placement of €19.8 Million at a €12 share price
29 Apr 2015
CRISPR Therapeutics Raises Additional $64 Million to Translate Breakthrough CRISPR-Cas9 Technology into Next Generation Therapies for Patients
16 Mar 2015
Chiasma Announces Mark Leuchtenberger as Chief Executive Officer
10 Mar 2015
Quest Diagnostics to enhance diagnosis of Pediatric Neurological Disorders with exclusive whole exome sequencing from Personalis
10 Mar 2015
Zogenix Announces Agreement of Sale of Zohydro(R) ER Business to Pernix for $100 Million at Closing Plus Potential Milestones of $283.5 Million
27 Feb 2015
Chiasma Announces Completion of $70 Million Series E Financing
16 Feb 2015
U.S. FDA approves anticancer agent LENVIMA™ (Lenvatinib Mesylate) as treatment for Radioactive Iodine-Refracory Differentiated Thyroid Cancer

 

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
News Archive
22 Dec 2015
eFFECTOR Therapeutics Raises $40 Million - Series B Financing
21 Dec 2015
Bayer and CRISPR Therapeutics AG join Forces to Discover, Develop and Commercialize Potential Cures for Serious Genetic Diseases
11 Dec 2015
CRISPR Therapeutics Appoints Tony Coles to its Board of Directors
11 Dec 2015
Senseonics Holdings, Inc. and ASN Technologies, Inc. Announce Closing of Merger
3 Dec 2015
Cytos Biotechnology and Kuros Biosurgery to combine to create Kuros Biosciences
2 Dec 2015
Kesios Therapeutics Raises £19 Million In Series A Financing
17 Nov 2015
Gynesonics Completes $46 million Equity Financing
12 Nov 2015
Sientra Appoints Jeffrey Nugent Chairman and Chief Executive Officer
26 Oct 2015
Vertex and CRISPR Therapeutics Establish Collaboration to Use CRISPR-Cas9 Gene Editing Technology to Discover and Develop New Treatments for Genetic Diseases
20 Oct 2015
Wilson Therapeutics Appoints Andrew Kay as Chairman
19 Oct 2015
Abingworth appoints Dr Shelley Chu
9 Oct 2015
Sientra Sends Letter to Plastic Surgeons Regarding Silimed-Manufactured Products
5 Oct 2015
Sientra Issues Statement Regarding Recent ANVISA Announcement
24 Sep 2015
Dear Doctor Letter
18 Sep 2015
Sientra® Prices Follow-On Public Offering of Common Stock
23 Jul 2015
GenSight Biologics Closes $36 Million Series B Preferred Stock Financing
23 Jul 2015
SutroVax raises $22 million in Series A
22 Jul 2015
Gynesonics Raises $43 million in Equity Financing
7 Jul 2015
Abingworth appoints Tim Haines and Kurt von Emster as joint Managing Partners
3 Jul 2015
MEDIAN Technologies announces a private placement of €19.8 Million at a €12 share price
29 Apr 2015
CRISPR Therapeutics Raises Additional $64 Million to Translate Breakthrough CRISPR-Cas9 Technology into Next Generation Therapies for Patients
16 Mar 2015
Chiasma Announces Mark Leuchtenberger as Chief Executive Officer
10 Mar 2015
Quest Diagnostics to enhance diagnosis of Pediatric Neurological Disorders with exclusive whole exome sequencing from Personalis
10 Mar 2015
Zogenix Announces Agreement of Sale of Zohydro(R) ER Business to Pernix for $100 Million at Closing Plus Potential Milestones of $283.5 Million
27 Feb 2015
Chiasma Announces Completion of $70 Million Series E Financing
16 Feb 2015
U.S. FDA approves anticancer agent LENVIMA™ (Lenvatinib Mesylate) as treatment for Radioactive Iodine-Refracory Differentiated Thyroid Cancer
 
Copyright Abingworth 2017